Blood antioxidant parameters in sickle cell anemia patients in steady state

Journal of the National Medical Association

Volumn 100, Issue 8, 2008, Pages 897-902

  Manfredini, Vanusa ^a,b   Lazzaretti, Luísa Lauermann ^a   Griebeier, Isabel Heinzmann ^a   Santin, Ana Paula ^b   Brandão, Vanessa Duarte Martins ^a,b   Wagner, Sandrine ^b   Castro, Simone Martins ^b   Peralba, Maria Do Carmo Ruaro ^b   Benfato, Mara Silveira ^a,b  

^a Centro de Biotecnologia   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidant enzymes; Oxidative damage; Sickle cell anemia

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE PEROXIDASE; LIPID; MALONALDEHYDE; PROTEIN; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; ASSAY; BIOLOGY; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOLYSATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MACROMOLECULE; MALE; MEMBRANE DAMAGE; OXIDATIVE STRESS; PARAMETER; PLASMA; PRIORITY JOURNAL; SERUM; SICKLE CELL ANEMIA; STEADY STATE;

EID: 50049134956     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0027-9684(15)31402-4     Document Type: Article

References (51)

1. Pauling L, Itano HA, Singer SR, et al. Sickle-cell anaemia, a molecular disease. Science. 1949;110:543-548.
2. Steinberg MH. Sickle Cell Anaemia and fetal haemoblobin. Am J Med Sci. 1994;308:259-265.
3. Glover RE, Ivy ED, Orringer EP et al. Detection of Nitrosyl Haemoblobin in Venous Blood in the Treatment of Sickle Cell Anaemia with Hydroxyurea. Mol Pharmacol. 1999;53:1006-1010.
4. Serjeant GR. Sickle Cell Disease. Lancet. 1997;350:725-730.
5. Beyer JE, Simmons LE. Home Treatment of Pain for Children and Adolescents with Sickle Cell Disease. Pain Manag Nurs. 2004;5:126-135.
6. Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. TRENDS Pharmacol Sci. 2006;27:204-210.
7. Wagener FADTG, Abraham NG, Kooyk YV, et al. Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation. TRENDS Pharmacol Sc. 2001;22:52-54.
8. Hebbel RP, Eaton JW, Balasingam M, et al. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982;70:1253-1259.
9. Rice-Evans C, Omorphos SC, Baysal E. Sickle cell membranes and oxidative damage. Biochem J. 1986;237:265-269.
10. 2 Isoprostanes in the Acute chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress. Am J Respir Crit Care Med. 2001;164:1248-1252.
11. Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2001;2:280-285.
12. Repka T, Hebbel, RP. Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. Blood. 1991;78:2753-2758.
13. Dhalla NS, Elmoselbi AB, Hata T, et al. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000;47:446-456.
14. Amer J, Ghoti H, Rachmilewitz E, et al. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol. 2005;132:108-113.
15. Halliwell B, Gutteridge JMC. Cellular responses to oxidative stress: adaptation, damage,repair, senescence and death. In: Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine, 3rd ed. New York: Oxford University Press; 2007:187-267.
16. Chiu D, Lubin B. Abnormal vitamin E and glutathione peroxidase levels in Sickle Cell Anaemia. J Lab Clin Med. 1979;94:542-548.
17. Natta CL, Chen LC, Chow CK. Selenium and Glutathione Peroxidase Levels in Sickle Cell Anaemia. Acta Haematol. 1990;83:130-132.
18. Antunes F, Salvador A, Marinho HS, et al. Lipid peroxidation in mitochondrial inner membranes I. An integrative Kinetic model. Free Radic Biol Med. 1996;21:917-943.
19. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J. 1996;313:17-28.
20. Stadman ER, Berkett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol. 1997;10:485-494.
21. Chiu D, Lubin B, Shohet SB. Peroxidative reactions in red cell biology. In: Pryor W, ed. Free Radicals in Biology. New York: Academic Press; 1982:115-160.
22. Chiu D, Claster S. Measurement of red cell membrane oxidation and generation of oxidative intermediates. In: Shohet S, Mohandas N, eds. Red cell membranes. New York: Churchil Livingstone; 1988:203-235.
23. Palek J, Liu SC. Dependence of spectrin organization in red blood cell membranes on cell metabolism: implication for control red cell shape, deformability, and surface area. Semin Hematol. 1979;14:75-93.
24. Lubin B, Chiu, D. Properties of vitamin E-deficient erythrocytes following peroxidant injury. Pediart Res. 1982;16:928-932.
25. Hebbel RP, Miller WJ. Phagocytosis of sickle erythrocytes: immunologic and determinants of hemolytic anaemia. Blood. 1984;64:733-741.
26. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464-478.
27. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med. 2002;32:797-803.
28. Wilson JB, Headlee ME, Huisman TH. A new high performance liquid chromatographic procedure for the separation and quantification of various haemoblobin variants in adults and newborn babies. J Lab Clin Med. 1983;102:174-186.
29. Kawamura, N. Catalase. In: Taniguchi N, Gutteridge JMC, eds. Experimental Protocols for Reactive Oxygen and Nitrogen Species. New York: Oxford University Press; 2000:77-80.
30. Pinto RE, Bartley W. Effect of age and sex on Glutathione reductase and Glutathione peroxidase activities and on aerobic Glutathione oxidation in rat liver homogenates. Biochem J. 1969;112:109-115.
31. Karatepe M. Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC-UV. LCGC North Am. 2004;22:362-365.
32. Gaetani GF, Ferraris AM, Rolfo M, et al. Predominant role of catalase in the disposal of hydrogen-peroxide within human erythrocytes. Blood. 1996;47:1595-1599.
33. Chan AC, Chow CK, Chiu D. Interaction of Antioxidants and Their Implication in Genetic Anaemia. Proc Soc Exp Biol Med. 1999;222:274-282.
34. Zimmermann CP, Natta C. Glutathione Peroxidase Activity in Whole Blood of Patients with Sickle Cell Anaemia. Scand J Haematol. 1981;26:177-181.
35. Dailly E, Urien S, Barré J, et al. Role of Bilirubin in the Regulation of the Total Peroxyl Radical Trapping Antioxidant Activity of Plasma in Sickle Cell Disease. Biochem Biophys Res Commun. 1998;248:303-306.
36. Asian M, Ryan TM, Adler B, et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in Sickle Cell Disease. Proc Natl Acad Sci USA. 2001;98:15215-15220.
37. Cesquini M, Torsoni MA, Stoppa GR, et al. t-BOOH-induced oxidative damage in sickle red blood cells and the role of flavonoids. Biomed Pharmacother. 2003;57:124-129.
38. Amstad P, Peskin A, Shah G, et al. The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry. 1991;30:9305-9313.
39. Cao C, Leng Y, Liu X, et al. Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine Kinases. Biochemistry. 2003;42:10348-10353.
40. Cao C, Leng Y, Kufe D. Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem. 2003;278:29667-29675.
41. Levine RL. Oxidative modification of glutamine synthetase 1. Inactivation is due to loss of one histidine residue. J Biol Chem. 1983;258:11823-11827.
42. Saha A, Adak S, Chowdhury S, et al. Enhanced oxygen releasing capacity and oxidative stress in diabetes mellitus and diabetes mellitus-associated cardiovascular disease: a comparative study. Clin Chim Acta. 2005;361:141-149.
43. Shacter E, Willians JA, Lim M, et al. Different susceptibility of plasma proteins to oxidative modification: examination by Western blot immunoassay. Free Radic Biol Med. 1994;17:429-437.
44. Belisario MA, Domenico Di C, Pelagalli A, et al. Metal-ion catalysed oxidation affects fibrinogen activity on aggregation and adhesion. Biochimie. 1997;79:449-455.
45. Choi J, Malakowsky CA, Talent JM, et al. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun. 2002;293:1566-1577.
46. Pignatelli B, Li C-Q, Boffetta P, et al. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res. 2001;61:778-784.
47. Das SK, Nair RD. Superoxide dismutase, glutathione peroxidative, catalase and lipid peroxidation of normal and sickle erythrocytes. Br J Haematol. 1980;44:87-92.
48. Lachant NA, Davidson WD, Tanaka KR. Impaired Pentose Phophate Shunt Function in Sickle Cell Disease: a Potential Mechanism for Increased Heinz Body Formation and Membrane Lipid Peroxidation. Am J Hematol. 1983;15:1-13.
49. Waugh SM, Willardson BM, Kannan R, et al. Heinz bodies induce clustering of band 3, glycophorin and ankyrin in sickle cell erythrocytes. J Lab Clin Invest. 1985;78:1155-1160.
50. Jain SK. The accumulation of malonyldialdehyde, a product of fatty acid peroxidatioacan disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J Biol Chem. 1984;259:3391-3394.
51. Schwartz S, Tanaka Y, Fidler ZY et al. Increased adherence of sickle and phosphatidylserine-enriched human erythrocytes to culture human peripheral blood monocytes. J Clin Invest. 1985;75:1965-1972.